Laurion Capital Management LP

Position in AZN — Astrazeneca PLC

CIK 1390202 NEW YORK, NY

Position in AZN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,137,720

-$735,870 QoQ

Shares Held

6,000

-36.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#638

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Laurion Capital Management LP holds $13,138,022 across 6 Drug Manufacturers - General names. AZN ranks #2 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	42,168	$10,611,155
2	AZN	Astrazeneca PLC This page	6,000	$1,137,720
3	LLY	ELI LILLY & Co	448	$537,344
4	MRK	Merck & Co., Inc.	3,197	$410,814
5	JNJ	Johnson & Johnson	1,417	$359,875
6	NVO	Novo Nordisk A S	1,692	$81,114

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,137,720	6,000	-36.8%	Shares	Sole	2026-08-13
2026-03-31	$1,873,590	9,500	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.